Detalles de la búsqueda
1.
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Am J Kidney Dis
; 77(1): 94-109, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33121838
2.
Experience with transplantation of human cryopreserved ovarian tissue to a sub-peritoneal abdominal site.
Hum Reprod
; 36(9): 2473-2483, 2021 08 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34255039
3.
Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency.
Am J Kidney Dis
; 75(1): 84-104, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31473020
4.
Treating Early-Stage CKD With New Medication Therapies: Results of a CKD Patient Survey Informing the 2020 NKF-FDA Scientific Workshop on Clinical Trial Considerations for Developing Treatments for Early Stages of Common, Chronic Kidney Diseases.
Kidney Med
; 4(4): 100442, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35372821
5.
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Diabetes
; 70(1): 1-16, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33106255
6.
Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists.
Am J Health Syst Pharm
; 79(1): e65-e70, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34185826
Resultados
1 -
6
de 6
1
Próxima >
>>